Search results
AMD STOPPER Offers New Hope to Sufferers of Age-Related Macular Degeneration | Healthcare Dive
Healthcare Dive· 1 day agoFearful of losing all of his central vision to the gradual blinding effects of Age-Related Macular Degeneration (AMD), a California-based researcher with ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
WTNH-TV New Haven· 19 hours agoHospital in Ústí nad Labem in the Czech Republic, have unveiled groundbreaking findings from a study showcasing the effectiveness of the Somavedic device in supporting individuals with wet age-related ...
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
WJTV Jackson· 7 days ago...Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that Sulagna Bhattacharya, Chief Executive Officer and Samarendra...application of Nanoscope's...
Toppling Goliath Brewing Co. partners with BREWS for BLiNDNESS
Brenham Banner-Press· 6 days agoToppling Goliath Brewing Co. has partnered with Iowa based Non-Profit BREWS for BLiNDNESS to support...
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 7 hours agoResearch analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating ...
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 6 days agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
WTRF Wheeling· 1 day agoPharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that ...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar opportunity,...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Morningstar· 6 days ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
Insider Monkey via Yahoo Finance· 5 days agoIn this article, we will be taking a look at the 12 cheap foods with anti-aging properties that...